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Summary 
Developmental commitment to Thl or Th2 responses 
critically influences host susceptibility to particular 
pathogens. We describe a novel mechanism govern- 
ing stable commitment to Th2 differentiation. Naive T 
cells develop strongly polarized Thl and Th2 profiles 
by 7 days after activation. However, commitment of 
these developing cells differs substantially. Although 
IL-4 reverses early Thl differentiation, IL-12 cannot 
reverse early Th2 differentiation. Thl reversibility re- 
sults from maintenance of IL-4 signal transduction, 
whereas Th2 commitment results from rapid loss of 
IL-12 signallng. The IL-12 signaling defect in Th2 cells 
results in failure to phosphorylate Jak2, Stat3, and 
Stat4. Since Th2 cells express the mRNA for the cloned 
murine IL-12 receptor 3 subunit, the signaling defect 
may involve expression or function of unidentified 
receptor components. The rapid extlnction of IL-12 
signaling in Th2 cells provides a demonstration of a 
mechanism for the stable commitment to a T helper 
phenotype. 
Introduction 
Differentiation of specific T helper (Th) subsets can deter- 
mine specific pathogen resistance or susceptibility, and 
underlies development of strong cellular or humoral im- 
mune responses (Mosmann and Coffman, 1989; Scott and 
Kaufmann, 1991; Bottomly, 1988). Interleukin-12 (IL-12) 
and IL-4 drive differentiation of naive T cells toward Thl 
or Th2 subsets, respectively (Hsieh et al., 1992, 1993a, 
1993b; Swain et al., 1990; Le Gros et al., 1990; Seder et 
al., 1993; Seder and Paul, 1994). Thl-type cells promote 
cell-mediated immunity, which protects against intracellu- 
lar pathogens. Some pathogens, such as Listeria monocy- 
togenes, induce protective Thl responses by rapidly acti- 
vating macrophage production of IL-12 (Hsieh et al., 
1993a, 1993b). Other pathogens, particularly Leishmania 
major, appear not to induce IL-12 production immediately 
upon infection, but rather delay induction of IL-12 for 5-7 
days (Reiner et al., 1994). While some murine strains 
(BlO.D2) eventually develop Thl responses and resist in- 
fection despite the lack of early IL-12 production, other 
strains (BALBlc) develop stable Th2 responses and suc- 
cumb (Fteiner et al., 1994). Helminthic infections, on the 
other hand, generally induceTh2 responses characterized 
by host T cell secretion of IL-4 (Urban et al., 1992). 
As a first step in defining the basis of these differential 
responses to pathogens, we have undertaken an analysis 
of the development and stability of Thl and Th2 pheno- 
types. Several lines of evidence motivated our examina- 
tion of the cytokine signaling pathways in early Th cells. 
First, IL-12 administration induces a resistant phenotype 
in BALB/c mice when administered concurrently with 
pathogens (Heinzel et al., 1993) but not when adminis- 
tered 7 days following infection (Sypek et al., 1993). Thus, 
a temporal window may limit the ability of IL-12 to alter 
Thl/Th2 development. Second, IL-4 dominates over IL-12 
in vitro for effects on Th cell development when both cyto- 
kines are present during primary antigen-driven activation 
(Hsieh et al., 1993b; Schmitt et al., 1994a), suggesting 
that IL-4 may block IL-12 signaling at some level. Finally, 
we recently demonstrated that the differences in Thl/Th2 
development between the strains BlO.D2 and BALB/c are 
due to differences in the T cells, and not in the antigen- 
presenting cells (APCs) (Hsieh et al., 1995). This result 
suggests that strain-dependent differences in Tcell signal- 
ing pathways could influence pathogen susceptibility. 
Thus, we initiated an examination of the developmental 
regulation of the IL-4 and IL-12 signaling pathways in Thl 
and Th2 cells. 
In the present study, we have identified a novel mecha- 
nism that explains several features of Thl/Th2 develop 
mental regulation. Thl cells retain the capacity to signal 
in response to IL-12 and to IL-4, whereas Th2 cells func- 
tionally extinguish the IL-12 receptor signaling pathway 
within 3 days after primary activation. Several conse- 
quences for T cell development are evident. First, IL-4 
can reverse phenotype development of early Thl cells. 
Second, IL-4 dominates over IL-12 for phenotype induc- 
tion. Third, IL-4-treated naive T cells rapidly acquire a per- 
manent commitment to theTh2 phenotype. The molecular 
site of the IL-12 signaling defect in Th2 cells appears 
closely associated with the IL-12 receptor. Thus, although 
both Thl and Th2 cells express Jak2, Stat3, and Stat4, 
IL-12 induces phosphorylation of these proteins only in 
Thl cells. Moreover, Thl and Th2 cells both bind IL-12 
with identical binding characteristics and express similar 
levels of the mRNA for the cloned murine IL-12 receptor 
8 chain. These results suggest that as yet unidentified 
receptor components may participate in the observed ef- 
fects. Strain-specific differences in this down-regulatory 
mechanism could provide a basis for the susceptibility of 
certain mouse strains to pathogens such as L. major, in 
which IL-12 induction is delayed rather than immediate. 
Results 
Th2 Ceils Rapidly Develop Phenotype Irreversibility 
To examine early differentiation and commitment of Th 
subsets, we isolated Mel-14”’ CD4+ T cells from DO1 1.10 
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Figure 1. Thl Cells Can Be Reversed Toward the Th2 Phenotype, 
While Th2 Cells Exhibit Phenotype Irreversibility 
(A) FACS-sorted naive CD4’ DO1 1 .I0 T cells (2 x 106) were cultured 
for 7 days with OVA peptide (0.25 PM) and 6 x 10 irradiated BALB/c 
splenocytes in the presence of 10 U/ml IL-12 plus 10 Kg/ml anti-IL-4 
to promote Thl differentiation, or 200 U/ml IL4 plus 3 &ml anti-IL-12 
to promote Th2 differentiation. Cultures were harvested on day 7, 
washed, and restimulated at 1.25 x 1 ob T cellslwell with OVA peptide 
and BALB/c splenocytes in the presence of the indicated cytokines 
or anticytokine antibodies. Supernatants collected after 46 hr were 
analyzed by ELISA for IFNT. 
(B) T cells were harvested on day 7 after secondary stimulation in 
the presence of the indicated conditions, washed, and restimulated 
(tertiary stimulation) at 2.5 x 105 T cells/well with OVA peptide and 
T cell receptor (TCR) transgenic mice by flow cytometry. 
Activation of these naive T cells by OVA peptide and irradi- 
ated BALBlc splenocytes in the presence of IL-12 plus 
anti-IL-4 monoclonal antibody (MAb), or IL4 plusanti-IL-12 
MAb for 7 days produced T cells with strongly polarized 
cytokine production. Naive T cells primed in the presence 
of IL-12 plus anti-IL-4 produced 500 U/ml of interferon-y 
(IFNy) and undetectable IL-4 upon restimulation, whereas 
naive T cells primed in the presence of IL-4 plus anti-IL-1 2 
produced 300 U/ml of IL4 and undetectable IFNy (data 
not shown). Although this degree of polarization indicates 
a fully differentiated cytokine profile for these early Thl 
and Th2 cells, their commitment to a particular Th pheno- 
type lineage may not be complete. 
To examine this issue, we imposed conditions for rever- 
sal of phenotype differentiation on these early Thl and 
Th2 cells. First, we restimulated Thl cells in the presence 
of IL4, IL4 plus anti-IL-12, anti-IL-12 alone, IL-12, or with- 
out additions, and measured the effects on immediate cy- 
tokine production (at 48 hr) and the effects on phenotype 
development (cytokine production upon restimulation) 
(Figure 1). These early Thl cells clearly maintained re- 
sponsiveness to both IL-12 and IL4 for modulation of im- 
mediate cytokine secretion (Figure 1A). Thus, addition of 
IL-12 increased IFNy production by nearly 2-fold, whereas 
neutralization of IL-12 reduced IFNy production by 70%. 
Addition of IL4 also reduced IFNy production by nearly 
50%. Furthermore, these Thl cells could undergo long- 
term alterations in phenotype caused by either IL-12 or 
IL4(Figure 1B). Additionof IL-4duringthesecondarystim- 
ulation induced subsequent IL4 production and reduced 
subsequent IFNy production. Thus, early Thl cells re- 
spond to both IL4 and IL-12 for immediate modulation of 
cytokine production and for Th phenotype reversal. These 
results suggest that developing Thl cells retain the capac- 
ity to transduce signals for IL4 and IL-12. 
We next examined the phenotype commitment of early 
Th2 cells. We restimulated Th2 cells in the presence of 
IL-12, IL-12 plus anti-lL4, anti-lL4, IL4, or without any 
additions and examined immediate cytokine production 
and subsequent phenotype development (Figure 1A). In 
contrast with Thl cells, Th2 cells were unaffected by any 
conditions both for immediate cytokine modulation and for 
phenotype reversal. Despite the addition of high levels of 
IL-12 or the neutralization of IL4, we detected no IFNy 
production either immediately or upon restimulation after 7 
days. Furthermore, neither IL-2 nor IFNy addition restored 
the ability of IL-12 to induce IFNy in Th2 cells (data not 
shown). IL-4 production remained in the range of 300450 
U/ml regardless of the experimental conditions. Thus, the 
observed resistance of Th2 cells to phenotype reversal by 
IL-12 suggested that a loss of IL-12 signaling may accom- 
pany early Th2 differentiation. 
BALB/c splenocytes without any added conditions. Supernatants were 
collected after 46 hr and analyzed by ELISA for IFNy and 114. 
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lnabillty of IL-12 to Induce Nuclear Factors 
In Developing Th2 Cells 
The inability of IL-12 to reverse early Th2 differentiation 
could either be due to a loss of IL-12-mediated signaling 
or to a dissociation of IL-12-induced signals from effects 
on differentiation. To distinguish these possibilities, we 
examined responses of developing Thl and Th2 cells to 
several cytokines by electrophoretic mobility shift assays 
(EMSAs) using oligonucleotide probes that bind mem- 
bers of the STAT family of transcription factors. The m67 
probe is derived from the serum-inducible element (SIE) 
of the c-fos promoter (Wagner et al., 1990) and the FcyRl 
probe contains the IFNy response region (GRR) from the 
promoter of the high affinity Fey receptor (Larner et al., 
1993). To control for the quality of nuclear extracts, we 
examined binding of these extracts to a probe specific for 
the ubiquitous and constitutive nuclear factor NF-Y (Szabo 
et al., 1993). We found a selective difference between 
early Thl and Th2 cells for IL-1 2 signaling (Figure 2). IL-1 2 
induced EMSA complexes with both the m67 SIE and 
FcyRl probes in Thl cells but not in Th2 cells. The inability 
of Th2 cells to form complexes with these probes was 
specific to IL-1 2, since both IL-4 and IFNa induced EMSA 
complexes with these probes in both Thl and Th2 cells 
(Figure 2). 
Notably, early Thl cells showed significantly reduced 
formation of DNA-binding complexes when treated with 
IFNy compared with Th2 cells (Figure 2). Since Thl cells 
produce IFNy during activation, we suspected that ligand- 
mediated receptor desensitization could explain this loss 
of IFNy signaling. To test this hypothesis, we treated Th2 
cells with IFNy for 7 days and measured IFNy-induced 
EMSA complexes (data not shown). This prolonged expo- 
sure of Th2 cells to IFNy produced a specific reduction in 
IFNy-induced EMSA complexes. In contrast, IL4 and 
IFNa both induced EMSA complexes in both IFNy-treated 
and untreated Th2 cells. We conclude that loss of IFNy 
responsiveness by early Thl cells reflects ligand-induced 
desensitization. In contrast, the loss of IL-12 sensitivity by 
Th2 cells cannot be due to ligand-mediated desensitiza- 
tion, since these cells never encounter IL-12 during their 
development. 
We previously found that IL-12-induced complexes in 
the Thl clone 3F6 contained Stat1 , Stat3, and Stat4 (Ja- 
cobson et al., 1995), but have not examined the composi- 
tion of these complexes in naive or early T cells. Thus, 
we used antibodies raised against the STAT proteins 
(Zhong et al., 1994a, 1994b) to identify the components 
of IL-12-induced complexes in early Thl and Th2 cells. 
Similar to our earlier findings, IL-la-induced EMSA com- 
plexes contained Statl, Stat3, and Stat4 in developing 
Thl cells (Figure 3A). In contrast, IL-12 failed to induce 
any STAT-containing complexes in developing Th2 cells. 
These differences between early Thl and Th2 cells were 
specific, since IFNa induced the expected Statlcontain- 
ing complexes in both Thl and Th2 cells (Figure 38). 
These findings further suggest that developing Th2 cells 
are selectively unresponsive to IL-1 2 for induction of tran- 
scription factors of the STAT family. 
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Figure 2. Loss of IL-12 Responsiveness in Developing Th2 Cells 
Thl and Th2 differentiation was induced in naive TCR transgenic T 
cells as described in Experimental Procedures. On day 7 after primary 
antigen activation, nuclear extracts were prepared from these Thl and 
Th2 cells following incubation with either media, 200 U/ml IL-4 for 20 
min, 10 U/ml IL-12 for 25 min, 300 U/ml IFNa for 30 min, or 500 UI 
ml IFNy for 10 min. EMSA was performed using “P-labeled m67 SE, 
FcyRI, and Ea Y box oligonucleotide probes as described in Experi- 
mental Procedures. 
Selective Loss of IL-124nduced Phosphorylatlon 
of STAT Proteins In Th2 Cells 
Loss of IL-12-induced nuclear factors by early Th2 cells 
could result either from an absence of STAT proteins or 
from adefect in their activation. To distinguish these possi- 
bilities, we examined STAT expression and tyrosine phos- 
phorylation in response to IL-12. Total cellular lysates pre- 
pared from IL-1 Btreated or untreated Thl and Th2 cells 
7 days following primary activation were precipitated using 
antisera specific for Statl, Stat3, or Stat4 (Figure 4). Pre- 
cipitated STAT proteins were examined for phosphotyro- 
sine content by Western blot analysis using the anti- 
phosphotyrosine reagent RC20 (Figure 4). IL-12 treatment 
led to the selective tyrosine phosphorylation of Stat3 and 
Stat4 in Thl cells but not in Th2 cells (Figure 4). This lack 
of phosphorylation was not due to the absence of Stat3 
and Stat4 expression in Th2 cells, since both Thl and Th2 
cells expressed these proteins as determined by direct 
Western blotting. Thl cells may express slightly higher 
Stat4 than Th2 cells, but this difference alone is unlikely 
to account for the lack of detectable tyrosine phosphoryla- 
tion of Stat4 in Th2 cells. IL-12 also increased Stat1 phos- 
phorylation in Thl cells over constitutive levels. In con- 
trast, the level of Stat1 phosphorylation was unchanged 
in IL-1 P-treated Th2 cells. Thus, Th2 cells were selectively 
unresponsive to IL-12 for tyrosine phosphorylation of 
Stat1 , Stat3, and Stat4. 
Phosphorylation of STAT family members on critically 
conserved tyrosine residues leads to their association and 
activation for DNA binding (Shuai et al., 1994). The inability 
of IL-12 to induce tyrosine phosphorylation of STAT pro- 
teins in Th2 cells could thus explain the loss of IL-12- 
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Figure 3. IL-12-Induced Nuclear Complexes 
Contain Statl, Stat3, and Stat4 in Developing 
Thl Cells 
Nuclear extracts were prepared from Thl and 
Th2 cells on day 7 after primary antigen activa- 
tion following incubation with medium alone, 
or with (A) 10 U/ml IL-12 for 25 min or (6) 300 
U/ml IFNa for 30 min. EMSA was performed 
using the m67 SIE probe and included normal 
rabbit serum (NM) or the indicated anti-STAT 
antisera. 
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induced nuclear factors. In addition, the ThP-selective loss 
of IL-I 2-induced STATphosphorylation, with maintenance 
of STAT protein expression in Thl and Th2 cells, localizes 
the IL-12 signaling defect in Th2 cells to a point proximal 
to STAT protein phosphorylation. 
IL-IP-Induced STAT Activation Is Extinguished 
Rapidly during Th2 Differentiation 
As shown above, Th2 cells lost IL-18induced activation 
of STAT factors by day 7 following primary activation (see 
Figures 2,3, and 4). To determine how rapidly this effect 
occurs, we induced Thl or Th2 differentiation in FACS- 
purified naive transgenic CD4+ Tcells and examined Stat4 
expression and IL-1 P-induced tyrosine phosphorylation on 
days 3 and 5 following activation (Figure 5). A significant 
loss of IL-l e-induced Stat4 phosphorylation was evident in 
the IL+treated T cell cultures as early as 3 days following 
primary T cell activation. However, Stat4 was clearly ex- 
pressed in both developing Thl and Th2 cells. By day 5 
following primary T cell activation, the loss of IL-12- 
induced Stat4 activation in Th2 cells was complete, de- 
spite thecontinued expression of Stat4 protein. Thus, con- 
ditions of Th2 development lead to the rapid loss of IL-12 
signaling. 
Jak2 and Tyk2 Expression In Developing Thl 
and Th2 Dells 
IL-12 induces the tyrosine phosphorylation of the Jak2 and 
Tyk2 kinases (Bacon et al., 1995), suggesting the partici- 
pation of these kinases in IL-12 signaling. To localize the 
defect in IL-12 signaling in Th2 cells, we examined the 
expression and activation of Jak2 and Tyk2 in developing 
Thl and Th2 cells (Figure 6). Jak2 and Tyk2 proteins were 
both clearly expressed in Thl and Th2 cells. Interestingly, 
Jak2 expression in Th2 cells appeared slightly reduced 
compared with Thl cells and showed a distinct banding 
pattern on Western blot analysis. The pattern of other ki- 
nases, including Jakl (data not shown) and TykP (Figure 
6) and that of the STAT proteins was not different between 
Thl and Th2 cells (see Figures 4 and 5). Thus, the distinct 
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Figure 4. IL-12 Induces Tyrosine Phosphorylation of Statl, Stat3 and 
Stat4 in Thl Cells but Not in Th2 Cells 
On day 7 after primary antigen activation, whole cell lysates from Thl 
and Th2 cells (3.5 x 103 were prepared after treatment for 25 min with 
medium alone or with 10 U/ml 11-12. Lysates were immunoprecipitated 
with the indicated anti-STAT antisera, separated by SDS-PAGE (7% 
gel), transferred to nitrocellulose, and probed with antf-phosphotyro- 
sine reagent RC20. Following exposure, blots were stripped and re- 
probed with the indicated STAT antisera. 
pattern of JakP banding in Th2 cells does not appear to 
result from a general increase in protein degradation in 
Th2 cells. Tyrosine phosphorylation of Jak2 induced by 
IL-12 occurred in Thl cells, but not in Th2 cells. Thus, the 
defect in IL-1 2 receptor signaling in early Th2 cells is not 
simply due to a loss of expression of JakP or TykP kinase, 
and may reside upstream of Jak2 kinase activation. 
Similar Expression of IL-12 Receptor by Thl 
and Th2 Cells 
Since the IL-1 2 signaling defect in Th2 cells appeared to 
reside upstream of the JakP kinase, we next examined 
the low affinity IL-12 receptor on Thl and Th2 cells by 
flow cytometry and radioligand binding analysis (Figure 
7). First, we used an indirect staining protocol to examine 
Day 3: 
Day 5: 
Thl Th2 
II 
-+ -+ 
Blot 
a Stat4 
a P-Y 
a Stat4 
1 2 3 4 
Figure 5. The IL-I 2 Signaling Pathway Is Rapidly Extinguished in De- 
veloping Th2 Cells 
Naive CD4+ DDl 1 .I0 T cells were stimulated with OVA peptide and 
irradiated SAL& spfenocytes with IL-12 plus anti-IL-4 to promote Thl 
differentiatfonorwith lL-4plusantttlL-12topromoteTh2differentiation. 
On day 3 and day 5 after primary antigen acttvatttn whole cell lysates 
from developing Thl and Th2 cells (6 x lq were prepared after 
incubation for 25 min with medium alone or with 10 U/ml IL-12. Lysates 
were immunoprecipitated wfth Stat4 antiserum, separated by SDS- 
PAGE (7% gel), transferred to nitrocellulose, and probed with an anti- 
phosphotyrosine reagent RC20. Following exposure, blots were 
stripped and reprobed with anti-Stat4 antisera. 
IL-12 binding sites by flow cytometry (Figure 7A). By this 
technique, levels of IL-12 receptors appeared similar for 
Thl and Th2 cells. The detection of the IL-12 receptor 
with this technique was specific, since no staining was 
observed using the cell line EL4.0VA, which lacks IL-12 
receptor and is IL-12 unresponsive. Purified CD4+ naive T 
cells expressed no detectable IL-12 receptors, consistent 
with the lack of IL-1 2 receptor expression by resting human 
peripheral T cells (Chiuonite et al., 1992; Desai et al., 
1992). Second, we used radioiodinated murine IL-12 to 
quantitate IL-1 2 receptor expression on Thl and Th2 cells 
by Scatchard analysis (Figure 78). Thl and Th2 cells ex- 
pressed looO-15CNl IL-12 binding sites with similar disso- 
ciation constants (Ko) ranging from 30-40 pM. Thus, Thl 
and Th2 cells express similar numbers of IL-12 binding 
sites. 
Recently, a cDNA encoding the murine IL-12 receptor 
9 component has become available (A. Chua and U. G., 
unpublished data). We therefore examined the expression 
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Figure 6. Loss of IL-1Plnduced Jak2 Kinase Tyrosine Phosphoryla- 
tion in Developing Th2 Cells 
Whole cell lysates were prepared from Thl and Th2 cells (4 x 103 
on day 5 after secondary antigen activation following incubation for 
10 min with medium alone or with 10 U/ml IL-12 and immunoprecipi- 
tated with antiserum to either Jak2 or Tyk2. Following separation by 
SDS-PAGE (7.5% gel) and transfer to nitrocellulose, the blot was 
probed with theanti-phosphotyrosineantibody4G10, followed bystrip- 
ping and reprobing with the respective Jak2 or TykP antisera. 
levels of this mRNA in early Thl and Th2 cells by Northern 
blot analysis (Figure 8). The results demonstrated that in 
these cells, the levels and expression patterns for the IL-12 
receptor p mRNA are very similar (the two transcripts de- 
tected represent alternate splice events; A. Chua and 
U. G., unpublished data). Thus, loss of IL-12 receptor sig- 
naling in Th2 cells is not due to the down-regulation nor 
the complete absence of the murine IL-1 2 receptor p chain. 
Discussion 
To evaluate the basis of Thl and Th2 phenotype develop- 
ment and stability, we have used the Doll.10 TCR 
transgenic system to characterize the early responses of T 
cells tovarious cytokines during phenotype differentiation. 
We find that the phenotype of early Thl T ceils was effi- 
ciently reversed by addition of 114. In contrast, Th2 ceils 
were clearly resistant to phenotype reversal, even in the 
presence of high levels of IL-12. Perez and colleagues 
(1995) have recently reported results similar to these find- 
ings. Thl development in some systems requires the coor- 
dinate action of IL-12 and IFNy (Schmitt et al., 1994b; 
Macatoniaet al., 1993). However, we found that IL-12 plus 
IFNy also failed to induce phenotype reversal of Th2 cells. 
To understand the molecular basis of these observations, 
we analyzed cytokine responsiveness in Thl and Th2 
cells. Thl cells were responsive to both IL4 and IL-12 as 
assessed by EMSA. In contrast, Th2 cells, while respon- 
sive to IL-4 and IFNy, were completely unresponsive to 
IL-12. Thus, this result suggests that a specific loss of 
IL-I 2 signaling may prevent developing Th2 cells from un- 
dergoing phenotype reversal. 
To evaluate this hypothesis, we focused on specific 
components of the IL-12 signaling pathway. Recently, we 
and others have demonstrated that IL-12 signaling in T 
ceils uses a unique Jak-STAT pathway (Jacobson et al., 
1995; Bacon et al., 1995). IL-I 2 was shown to induce the 
phosphorylation of the tyrosine kinases Jak2 and Tyk2 
in phytohemagglutinin-activated human peripheral T cells 
(Bacon et al., 1995). In addition, we have recently reported 
that IL-12 rapidly induces tyrosine phosphorylation of 
Statl, Stat3 and Stat4 in the Thl clone 3F6 (Jacobson 
et al., 1995). Thus, to assess IL-12 signaling specifically, 
we examined these STAT proteins and Jak family kinases 
in early Thl and Th2 cells. 
Th2 cells were unable to phosphorylate Stat1 , Stat3, or 
Stat4 in response to IL-1 2. This loss of the IL-l 2 signaling 
pathway occurred within 3 days following activation of na- 
ive T ceils in the presence of iL4. This signaling defect 
was not due to a lack of any of the identified proteins of 
the IL-l 2-induced Jak-STAT signaling pathway, including 
Statl, Stat3, Stat4, Jak2, and TykP (Figures 4 and 6). 
Moreover, these same signaling molecules were active in 
Th2 cells in distinct signaling pathways of other cytokines. 
For example, the IFNa and IFNy pathways that utilize TykP 
(IFNa) (Velazquez et al., 1992), Jak2 (IFN?) (Watling et 
al., 1993), and Stat1 (IFNa and IFN?) (Mulier et al., 1993) 
were intact in Th2 cells. Furthermore, early Thl and Th2 
cells expressed similar levels of IL-12 binding sites and 
similar forms of the cloned IL-12 receptor mRNA. Thus, 
weconclude that earlyTh2cellsspecificaliydown-regulate 
IL-12 signaling during their development from naive cells 
at a proximal step in the IL-12 receptor pathway. 
Potential Mechanisms of IL-12 Unresponsiveness 
in Th2 Ceils 
A cDNA was recently cloned that encodes a human IL-12 
receptor component representing the low affinity subunit 
(6 subunit) of the human IL-12 receptor complex (Chua 
et al., 1994). Presently, the putative additional subunit(s) 
required to generate a high affinity functional human IL-I 2 
receptor complex found on phytohemagglutinin-activated 
peripheral blood mononuclear cells is not yet identified 
(A. Chua. and U. G., unpublished data). We find that Thl 
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Figure 7. Comparable IL-12 Receptor Expression on Thl and Th2 
Cells 
(A) Detection of surface IL-12 receptor expression by flow cytometry. 
IL-12 receptor expression was quantitated using an indirect staining 
technique as described in Experimental Procedures. Naive CD4+ T 
cells, and Thl and Th2 cells on day 4 following secondary activation 
byantigen wereanalyzed for IL-12 receptorexpression. EL4.0VAcells 
were included as a negative control. 
(B) Detection of IL-12 binding sites by Scatchard analysis. Scatchard 
analysis was performed using ‘251-labeled murine IL-12 on Thl and 
Th2 cells on day 4 after secondary antigen-driven activation. 
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Figure 9. Expression of Murine IL-12 Receptor mRNA in Thl and Th2 
Cells 
Total cellular RNA was isolated from Thl and Th2 cells on days 7 
and 9 after secondary antigen activation, EL4.0VA, and TA3 cells. 
Northern blotting was performed using the full-length murine IL-12 
receptor p subunit cDNA as a probe. The blot was stripped and re- 
probed for GAPDH. 
and Th2 cells express similar numbers of IL-12 binding 
sites as determined by radioligand binding analysis and 
that these cells also express similar levels of the murine 
IL-12 receptor 8 mRNA. Therefore, it is likely that as for 
the human IL-12 receptor, the murine IL-12 receptor re- 
quires (an) additional subunit(s) to be functional. We can 
also speculate that the inability of Th2 cells to respond to 
IL-1 2 may be due to down-regulation or modification of this 
additional receptor subunit(s). It will thus be very important to 
evaluate the expression in Thl and Th2 cells of the other 
IL-12 receptor component(s) as they are identified. 
A second potential mechanism for the IL-12 unrespon- 
siveness observed in Th2 cells could be the down- 
regulation or modification/inactivation of one or more of 
the components of the IL-12 signaling pathway specifically 
in Th2 cells. While we were unable to demonstrate specific 
functional alterations in the signaling components of Th2 
cells, some differences were apparent by Western blot 
analysis. For example, when Jak2 was immunoprecipi- 
tated from Thl and Th2 cells, we observed distinct pat- 
terns of antigenic epitopes in these two cell types. In Th2 
cells, JakP may be modified in some posttranslational 
manner, resulting in loss of function. 
Implications for Immune Response Regulation 
The lossof IL-12 responsiveness in earlyTh2 development 
has important implications relevant for immune responses 
to pathogens, and may help to explain several previous 
observations. First, loss of IL-1 2 signaling may participate 
in the observed dominance of IL-4 over IL-12 in in vitro 
studies (Hsieh et al., 1993b; Schmitt et al., 1994a). Sec- 
ond, the rapid down-regulation of IL-12 signaling may dic- 
tate the temporal limits observed for the ability of IL-12 
for curing Leishmaniasis (Reiner et al., 1994; Sypek et al., 
1993). Furthermore, it is possible that genetic variation 
in this down-regulatory pathway could play a role in the 
strain-dependent susceptibility to pathogens, such as 
L. major, which show a delayed induction of IL-12. 
IL-4 dominates IL-12 for effects on Th phenotype differ- 
entiation in several systems. Hsieh et al. (1993b) found 
that addition of IL4 concurrently with IL-12 caused the 
differentiation of the naive DO1 1 .lO TCR transgenic T cell 
to the Th2 phenotype in a manner indistinguishable from 
cells induced with IL-4 alone. Moreover, Schmitt and col- 
leagues (1994a) have produced similar results using anti- 
CD3 polyclonal activation of naive CD4+ cells. IL-12 recep 
tors are not expressed by naive murine (Figure8) or resting 
human peripheral T cells (Chiuonite et al., 1992; Desai 
et al., 1992). Since IL4 receptors are apparently present 
on resting peripheral human and murine T cells (Foxwell 
et al., 1989; Lowenthal et al., 1988) IL-4 signaling may 
precede IL-12 signaling on activated naive T cells, prior 
to theexpressionof IL-12 receptors. Furthermore, IL-4can 
induce expression of the IL4 receptor (Ohara and Paul, 
1988; Dokter et al., 1992) further favoring development 
of the Th2 pathway. Thus, our finding of early extinction 
of IL-12 signaling may be relevant to the dominance of 
IL4 over IL-12 in Th phenotype differentiation. 
This finding may also explain the temporal window re- 
stricting the ability of IL-12 to cure L. major infection in 
susceptible BALB/c mice. IL-12 administered at the time 
of L. major infection confers a protective Thl phenotype 
in BALB/c mice (Heinzel et al., 1993; Sypek et al., 1993). 
However, IL-12 administration 7 days following infection 
fails to induce Thl development or to produce a cure (Sy- 
pek et al., 1993). Thus, the effectiveness of IL-12 in induc- 
ing protective Thl responses in BALB/c is limited to ashort 
time frame of less than 7 days. The rapid extinction of 
IL-12 receptor signaling we observed in vitro in developing 
Th2 cells from the BALB/c background may be the expla- 
nation for the limited temporal effectiveness of IL-12. 
In the initial stage of L. major infection, CD4+ T cells 
from both susceptible and resistant mice express similar 
levels of IL4 transcripts (Reiner et al., 1994). In suscep- 
tible BALB/c mice, IL-12 production is induced on days 
5-7following infection but is ineffective in altering the non- 
curative Th2 response. These results may be explained 
by our in vitro observation that BALBlc-derived early Th2 
cells are unresponsive to IL-12. In resistant strains (e.g., 
BlO.D2) IL-12 production on days 5-7 correlates with a 
down-regulation of ThP-type cytokine transcripts and the 
emergence of a curative Thl response (Reiner et al., 
1994). The ability of this delayed production of IL-12 to 
promote the development of Thl responses suggests a 
maintenanceoftheIL-12signalingpathwayin theTcellsof 
resistant mice. Therefore, it will be of interest to determine 
whether the loss of IL-12 responsiveness in Th2 cells cor- 
relates with the susceptible phenotype. 
Implications for Immune Therapy 
The efficacy of some vaccines, for example those to 
L. major, depend on the development and maintenance 
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of particular Th phenotypes (Afonso et al., 1994). There- 
fore, an understanding of the mechanisms governing phe- 
notype development and stability directly contribute to 
vaccine development. IL-1 2 has been proposed as a thera- 
peutic agent for redirecting predominant Th2 responses in 
parasitic infections and allergies (Scott et al., 1989; Scott, 
1993). Our resultssuggest that strategies todirect immune 
responses to specific antigens should take into consider- 
ation the potential for a unidirectional developmental path- 
way in which established Th2 responses may be much 
more difficult to reverse. 
Experlmentsl Procedures 
Cytoklnss snd Antlbodies 
Recombinant human IL-2 was provided by Takeda (Osaka, Japan), 
recombinant murine IL4 was provided by Genzyme (Cambridge, Mas- 
sachusetts), murine IL4 was also produced as high titer culture super- 
natant of transfected PSI5 mastocytoma cells, recombinant murine 
IL-12 was provided by Hoffmann-La Roche (Nutley. New Jersey), re- 
combinant human IFNaM, was provided by Hoffmann-La Roche (Ba- 
sel, Switzerland), and recombinant murine IFNy was provided by Gen- 
entech (South San Francisco, California). Anti-IL-4 MAb 11811 has 
been described (Ohara and Paul, 1985). Polyclonal goat anti-murine 
IL-12 antisera was supplied by Hoffmann-La Roche (Nutley, New Jer- 
sey). Anti-IL-12 MAb (TOSH) was provided by Drs. C. S. Tripp and 
E. R. Unanue (Washington University School of Medicine, St. Louis, 
Missouri) (Tripp et al., 1994). Polyclonal rabbit antisera specific for 
Statl, StatP, Stat3, and Stat4were provided by Dr. J. Darnell (Rockefel- 
ler University, NewYork, New York; Zhongetal., 1994a, lQQ4b). 4610, 
a murine anti-phosphotyrosine antibody, was provided by Dr. B. 
Drucker (Oregon Health Sciences University, Portland, Oregon). The 
anti-phosphotyrosine reagent RC20 was purchased from Transduction 
Laboratories (Lexington, Kentucky). Polyclonal rabbit antisera specific 
for Jak2 were purchased from Upstate Biotechnology (Lake Placid, 
New York). Polyclonal antisera specific for Tyk2 were purchased from 
Santa Cruz Biotechnology (Santa Cruz, California). Polyclonal goat 
anti-murine IL-12 was supplied by Hoffmann-La Roche (Nutley, New 
Jersey). 
Medium and Peptldes 
Cultures of T cells were maintained in Iscove’s modified Dulbecco’s 
Eagle Medium (Washington University Tissue Culture Support Center, 
St. Louis, Missouri) supplemented with 10% fetal calf serum (FCS) 
(Hyclone, Logan, Utah), 2 mM L-glutamine, 0.1 mM sodium pyruvate, 
0.1 mM MEM nonessential amino acids, 100 U/ml penicillin, 100 pgl 
ml streptomycin, and 50 pM P-mercaptoethanol. OVA peptide from 
chicken ovalbumin (residues 323-339) was synthesized on an Applied 
Biosystems model 430 peptide synthesizer (Foster City, California). 
Anlmals 
Mice transgenic for the DO1 1.10 af3-TCR (Murphy et al., 1990) were 
maintained on the BALB/c background. Female BALB/c mice were 
purchased from Harlan Sprague Dawley (Indianapolis, Indiana). 
Transgenlc T Cell Purlflcstlon 
CD4+ T cells from transgenic mice were purified and naive T cells 
were isolated by FACS sorting as described (Hsieh et al., 1995). FACS 
sorting generally yielded purities of >Q6% Mel-14WD4+ T cells. 
T Cell Cultures 
FACS-sorted naive CD4+ DO1 1 .lO T cells (2 x 103 were stimulated 
in 2 ml cultures with 0.25 uM OVA peptide presented by irradiated 
BALBlc splenocytes (2000 rads, 6 x lW/well) in the presence of 10 
U/ml IL-12 and 10 pg/ml anti-IL-4 (IIBII) to promote Thl phenotype 
development or 200 U/ml IL-4 and 3 Pa/ml anti-IL-1 2 (TOSH) to pro- 
mote Th2 phenotype development. At 72 hr, the cells were expanded 
Mold in fresh medium. These differentiated Thl and Th2 cells were 
harvested on day 7, washed, and counted. T cells (1.25 x Iv) were 
restimulated with OVA peptide and BALBlc splenocytes with or without 
addition of cytokines or anti-cytokine antibodies as indicated in the 
figure legends. Supernatants were collected after 46 hr and analyzed 
by capture enzyme-linked immunosorbent assay (ELISA) for IFNy 
(Buchmeier and Schreiber, lQ65). For tertiary stfmulattons, T cells were 
harvested on day 7 after secondary stimulation, washed, and counted. 
T cells (2.5 x 1Q) were restimulated with OVA and BALB/c spleno 
cytes without further additions to assess the effects of the conditions 
used for secondary stimulation on Th phenotype differentiation. Super- 
natants were wllected after 46 hr and analyzed by capture ELISA for 
IFNy and IL4 (Buchmeier and Schreiber, lga5; Hsieh et al., 1992). 
For immunoprecipitations and nuclear extract preparation from pri- 
mary stimulations, 1 x lad FAGS-sorted naive CDs+ DC1 1 .lO T cells 
were stimulated in 10 ml cultures with OVA peptide (0.25 PM) and 
irradiated BALB/c splenocytes (4 x IO? with IL-12 plus anti-IL-4 (Thl) 
or IL4 plus anti-IL-12 (Th2). At 72 hr, the cells were expanded l&fold 
in fresh medium containing 40 U/ml 11-2. Secondary stimulation of 
Thl and Th2 cells occurred on day 7 after primary activation and 
was carried out as described above. Cells from either the primary or 
secondary stimulation were washed and incubated in complete media 
with 2% FCB (for Jak21Tyk2 immunoprecipltations) or media con- 
taining 10% FCS for 3-12 hr prior to incubation with cytokines. 
Nuclear Extracts snd EMSA 
Nuclear extracts were prepared and EMSAs performed as described 
(Szabo et al., 1993). In brief, nuclear extracts (3 ug of protein) were 
incubated at room temperature with 32P-labeled double-stranded oligo- 
nucleotide probe (0.2 ng, 1 x 105 cpm) in binding buffer with 1 pg 
poly(dl-dC) for 30 min prior to separation by electrophoresis through 
a 5.25% polyacrylamide gel in 0.4 x Tris-borate-EDTA. Antibody su- 
pershifts were performed by adding 2 ul of diluted antiserum (diluted 
1:lO in binding buffer) to binding reactions for an additional 30 min 
of incubation. 
Ollgonuc~tldo Probes 
The following double-stranded oligonucleotides were used in EMSA 
experiments: m67 SIE, GTCGACATTTCCCGTAAATCGTCGA; FcyRl 
GRR, TCGACGTATTTCCCAGAAAAGGAACCTCGA; Ea Y box, TCG- 
ACAllnXTGATTGGTTAAAAGTC. The m67 SIE and FqRl probes 
bind to members of the STAT family of transcription factors. The Y 
box probe from the I-Ea chain promoter binds to the constitutive factor 
NF-Y. 
Immunopmclpltstlon and Western Blot Analysis 
Analysis of the tyrosine phosphorylation of STAT family members was 
performed essentially as described (Jacobson et at., lQQ5). In brief, 
total cellular lysates of 3-4 x IO’ T cells were immunoprecipitated with 
anti-STAT antisera and resolved by SDS-PAGE. Following transfer 
to nitrocellulose, blots were probed with RC20 (1:2500). Blots were 
stripped and reprobed with anti-STAT antisera (1:3000). For analysis 
of Jak2 and TykP kinase phosphorylation, total cellular lysates of 4 x 
10’ T cells were immunoprecipitated as described (Witthuhn et al., 
1993). The immunoprecipitates were resolved by SDS-PAGE and 
transferred to nitrocellulose. lmmunoblotting with anti-phosphotyro 
sine MAb 4GlO and reprobing with antiserum against Jak2 or Tyk2 
was performed as, described (Bacon et al., 1995). 
flow Cytometric Analysis 
Cells (1 x 1 q were incubated at 4OC for 2 hr with 100 ng of recombi- 
nant murine IL-12 (7 nM) in a total volume of 200 pl of staining buffer 
(phosphate-buffered saline [PBS] containing 10% FCS and 2% normal 
rabbit serum). Cells were washed three times and resuspended in 106 
ul of staining buffer wntaining 1 pg of polyclonal goat anti-murine 
11-12. After incubation for 30 min. cells were washed three times and 
incubated for 30 min in staining buffer with biotinylated rabbit antigoat 
immunoglobulin G (Vector Laboratories, Burlingame, California). Cells 
were then washed three times with PBS (lacking serum) and incubated 
for 30 min in 1013 nl of PBS containing streptavidin-phycoerythrin wn- 
jugate (Chromoprobe. Incorporated, Redwood City, California). Cells 
were washed, resuspended in 400 cl of PBS, and analyzed by flow 
cytometry on a Becton Dickinson FACScan (Becton Dickinson, Brain- 
tree, Massachusetts). 
Scatchard Analysis 
IL-12 binding sites on Thl and Th2 cells were quantitated by radioli- 
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gand binding analysis using lZSI-labeled murine IL-12 essentially as 
described (Chizzonite et al., 1992). Recombinant murine IL-12 was 
radioiodinated using Bolton-Hunter reagent (Bolton and Hunter, 1973) 
(Amersham, Indianapolis, IN). 
Northern Blot Analysis 
Total RNA was isolated from Thl and Th2 cells using RNAzol RNA 
isolation solvent (Tel-Test, Friendswood, Texas). Northern blot analy- 
sis was performed with 15 pg of total RNA per lane using standard 
procedures. The full-length murine IL-12 receptor cDNA, which was 
used as a probe, was cloned by homology to the human IL-12 receptor 
(U. G., unpublished data). 
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